jueves, 17 de octubre de 2019

NIAID Funding News, October 16, 2019

NIAID Logo

October 16, 2019 NIAID Funding News

Feature Articles 

Apply Early To Guard Against Electronic Submission Errors

To successfully submit an electronic grant application, you need to pass two automated systems validations: Grants.gov and eRA Commons. Waiting until the last minute to apply will limit your ability to resolve any problems that may arise.

Opportunities and Resources

The K22 program is meant to support biomedical and behavioral postdoctoral scientists transitioning from non-independent training positions into full-time assistant professorships.
NIAID is interested in research on the influence and intersection of sex and gender factors in disease conditions, particularly in the context of HIV infection and other infectious, immunologic, and allergic diseases.
NIH will support clinical sites conducting clinical trial pediatric research in five focus areas: pre-, peri-, and post-natal outcomes; obesity; upper and lower airways; neurodevelopment; and positive health.

In The News

We have a reminder and updates for investigators proposing to use human fetal tissue in their grant, cooperative agreement, or research and development contract.
NIH’s Office of Research on Women’s Health is seeking feedback on a proposed prize competition, and NIH’s Sexual & Gender Minority Research Office will host a listening session next Tuesday, October 22, 2019.
Before applying for the Fiscal Year 2020 HHS SBIR Contract Solicitation, take a moment to review materials from the August 7, 2019 pre-proposal conference webinar.

Advice Corner

A small business concern is a for-profit, domestically owned and operated organization with no more than 500 employees. Before applying for NIH funding, such organizations must complete several registrations.

Reader Questions

New Funding Opportunities

  • RFA-AI-19-059, Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01, Clinical Trial Not Allowed)
  • PAR-20-029, Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01, Clinical Trial Not Allowed)
  • RFA-AI-19-065, Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21, Clinical Trial Not Allowed)
  • RFA-HD-20-002, Pediatric HIV/AIDS Cohort Study (PHACS) 2020 (P01, Clinical Trial Not Allowed)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.

No hay comentarios: